SCHEMBL6849293

SCHEMBL6849293

O=S(=O)(O)c1ccccc1N1CCNC(Cl)C1

nearest known ligand 0.43

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 8/20 0.43
MYC P01106 1/20 0.41
NOTUM Q6P988 2/20 0.35
ADRB1 P08588 4/20 0.34
DRD2 P14416 1/20 0.33
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
RPS6KB1 P23443 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2849210 0.84 MYC (0.45) HTR6MYCDRD2ALDH1A1LMNA
Water SCHEMBL5996484 0.83 MYC (0.44) HTR6MYCDRD2ALDH1A1LMNA
SCHEMBL6288232 0.83 HTR6 (0.43) HTR6MYCNOTUMADRB1DRD2
SCHEMBL6849062 0.81 RPS6KB1 (0.47) HTR6MYCNOTUMRPS6KB1
SCHEMBL6847420 0.80 HDAC1 (0.41) HTR6MYCADRB1DRD2ALDH1A1
SCHEMBL6848056 0.80 LATS1 (0.40) HTR6MYCNOTUMADRB1DRD2
SCHEMBL2851145 0.78 ADRB1 (0.41) HTR6MYCADRB1DRD2
SCHEMBL6847591 0.78 HTR6 (0.39) HTR6MYCNOTUM
SCHEMBL8632814 0.77 HTR6 (0.67) HTR6MYCADRB1DRD2ALDH1A1
Water SCHEMBL6904877 0.76 HTR6 (0.65) HTR6MYCADRB1DRD2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100486574-C Remedies and/or preventives for nervous system disorders MITSUBISHI PHARMACEUTICALS INC (JP) 2009-05-13 CN claimed
CN-1946396-A Medicine for prevention and/or treatment of ischemic circulatory disease MITSUBISHI PHARMA CORP (JP) 2007-04-11 CN claimed
CN-1638773-A Pharmaceutical preparation containing aminobenzenesulfonic acid derivative as active ingredient MITSUBISHI PHARMA CORP (JP) 2005-07-13 CN claimed
CN-1533292-A Medicament inhititing sodium/calcium exchange system 三菱制药株式会社 2004-09-29 CN claimed
CN-1496261-A Remedies and/or preventives for diabetic ischemic heart diseases 三菱制药株式会社 2004-05-12 CN claimed
EP-1374868-A1 REMEDIES AND/OR PREVENTIVES FOR DIABETIC ISCHEMIC HEART DISEASES Mitsubishi Pharma Corporation (JP) 2004-01-02 EP claimed
CN-1434724-A Remedies and/or preventives for nervous system disorders MITSUBISHI PHARMACEUTICALS INC (JP) 2003-08-06 CN claimed
CN-100502861-C Medicament inhibiting sodium/calcium exchange system MITSUBISHI PHARMA CORP (JP) 2009-06-24 CN disclosed
CN-100486574-C Remedies and/or preventives for nervous system disorders MITSUBISHI PHARMACEUTICALS INC (JP) 2009-05-13 CN disclosed
CN-1946396-A Medicine for prevention and/or treatment of ischemic circulatory disease MITSUBISHI PHARMA CORP (JP) 2007-04-11 CN disclosed
CN-1638773-A Pharmaceutical preparation containing aminobenzenesulfonic acid derivative as active ingredient MITSUBISHI PHARMA CORP (JP) 2005-07-13 CN disclosed
CN-1533292-A Medicament inhititing sodium/calcium exchange system 三菱制药株式会社 2004-09-29 CN disclosed
CN-1496261-A Remedies and/or preventives for diabetic ischemic heart diseases 三菱制药株式会社 2004-05-12 CN disclosed
EP-1374868-A1 REMEDIES AND/OR PREVENTIVES FOR DIABETIC ISCHEMIC HEART DISEASES Mitsubishi Pharma Corporation (JP) 2004-01-02 EP disclosed
CN-1434724-A Remedies and/or preventives for nervous system disorders MITSUBISHI PHARMACEUTICALS INC (JP) 2003-08-06 CN disclosed